SCHEMBL20914412

SCHEMBL20914412

CCOc1cccc2oc(-c3c(C)[nH]c4c(-c5ccccc5)c(C(F)(F)F)nn4c3=O)nc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F2RL3 Q96RI0 4/20 0.37
▸ POLB P06746 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ MAT2A P31153 2/20 0.33
▸ ARF6 P62330 2/20 0.33
▸ ADORA3 P0DMS8 1/20 0.32
▸ ADORA2A P29274 1/20 0.32
▸ ADORA1 P30542 1/20 0.32
▸ ALPL P05186 1/20 0.32
▸ PDE5A O76074 2/20 0.32
▸ PDE1A P54750 1/20 0.32
▸ PDE1B Q01064 1/20 0.32
▸ PDE1C Q14123 1/20 0.32
▸ UTRN P46939 1/20 0.32
▸ CEPT1 Q9Y6K0 1/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20914323 0.92 F2RL3 (0.41) F2RL3POLBKDM4EMEN1ALDH1A1
SCHEMBL20914046 0.91 POLB (0.34) F2RL3POLBKDM4EMEN1ALDH1A1
SCHEMBL20914061 0.91 CEPT1 (0.37) F2RL3POLBKDM4EMEN1ALDH1A1
SCHEMBL20914003 0.91 ARF6 (0.34) F2RL3POLBKDM4EMEN1ALDH1A1
SCHEMBL20819069 0.91 TNKS (0.37) F2RL3POLBKDM4EMEN1ALDH1A1
SCHEMBL20913960 0.90 F2RL3 (0.41) F2RL3POLBKDM4EMEN1ALDH1A1
SCHEMBL20913917 0.90 CEPT1 (0.36) F2RL3POLBKDM4EMEN1ALDH1A1
SCHEMBL20913908 0.89 F2RL3 (0.38) F2RL3POLBKDM4EMEN1ALDH1A1
SCHEMBL20914293 0.88 KDM4E (0.37) POLBKDM4EMEN1ALDH1A1KMT2A
SCHEMBL20914411 0.87 POLB (0.39) F2RL3POLBKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof NLRP3, NLRP1, P2RX7 F2RL3 1469/4885POLB 4311/4885KDM4E 1922/4885
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF NLRP3, NLRP1, P2RX7 F2RL3 1469/4885POLB 4311/4885KDM4E 1922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback